Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLA-DRA Antikörper (AA 26-254)

Der Kaninchen Polyklonal anti-HLA-DRA Antikörper wird verwendet zum Nachweis von HLA-DRA in Proben von Human. Er wurde validiert für WB, IHC, FACS und ELISA.
Produktnummer ABIN7600948
500,50 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 8 bis 12 Werktagen

Kurzübersicht für HLA-DRA Antikörper (AA 26-254) (ABIN7600948)

Target

Alle HLA-DRA Antikörper anzeigen
HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Reaktivität

  • 151
  • 18
  • 11
  • 10
  • 9
  • 9
  • 4
  • 3
  • 3
  • 1
Human

Wirt

  • 89
  • 76
  • 4
  • 1
  • 1
Kaninchen

Klonalität

  • 102
  • 69
Polyklonal

Konjugat

  • 91
  • 13
  • 9
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser HLA-DRA Antikörper ist unkonjugiert

Applikation

  • 80
  • 66
  • 54
  • 51
  • 25
  • 20
  • 13
  • 9
  • 9
  • 5
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), ELISA
  • Bindungsspezifität

    • 8
    • 8
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 26-254

    Verwendungszweck

    Anti-HLA-DR/HLA-DRA Antibody

    Spezifität

    No cross reactivity with other proteins.

    Kreuzreaktivität (Details)

    No cross-reactivity with other proteins.

    Produktmerkmale

    Anti-HLA-DR/HLA-DRA Antibody. Tested in ELISA, Flow Cytometry, IHC, WB applications. This antibody reacts with Human.

    Aufreinigung

    Immunogen affinity purified.

    Immunogen

    E.coli-derived human HLA-DR/HLA-DRA recombinant protein (Position: I26-L254).

    Isotyp

    IgG
  • Applikationshinweise

    Western blot, 0.25-0.5 μg/mL, Human Immunohistochemistry (Paraffin-embedded Section), 0.5-1 μg/mL, Human Flow Cytometry (Fixed), 1-3 μg/1x106 cells, Human ELISA, 0.1-0.5 μg/mL, -

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Konzentration

    500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    HLA-DRA (HLA Class II DR alpha (HLA-DRA))

    Andere Bezeichnung

    HLA-DRA

    Hintergrund

    Background: HLA class II histocompatibility antigen, DR alpha chain?is a?protein?that in humans is encoded by the HLA-DRA?gene. It is mapped to 6p21.32. HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5.

    Gene Full Name: major histocompatibility complex, class II, DR alpha

    Molekulargewicht

    37 kDa

    UniProt

    P01903

    Pathways

    T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Sie sind hier:
Chat with us!